Brexanolone: panacea for postpartum depression? Reply to: ‘Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?’
Main Authors: | Ajay Kumar Shukla, Ratinder Jhaj, Balakrishnan Sadasivam |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-02-01
|
Series: | Therapeutic Advances in Psychopharmacology |
Online Access: | https://doi.org/10.1177/2045125321997293 |
Similar Items
-
Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?
by: Justin Faden, et al.
Published: (2020-11-01) -
Treating Postpartum Depression: What Do We Know about Brexanolone?
by: Muneeza Ali, et al.
Published: (2021-07-01) -
Brexanolone: an allosteric modulator of GABA-A receptors in the rapid treatment of postpartum depression
by: Samet Kose, et al.
Published: (2017-10-01) -
Brexanolone, a GABAA Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review
by: Amber N. Edinoff, et al.
Published: (2021-09-01) -
Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience [version 1; peer review: 4 approved]
by: Bernhard Lüscher, et al.
Published: (2019-05-01)